Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in newborns [1]. It is an effective inhibitor of CYP3A4 that patently increases circulating levels of some other HMG-CoA reductase inhibitors [20].
mathematical modeling method based on the concept of a dynamic system in mathematical modeling in pharmacokinetics [3-14]. An additional objective was to motivate researchers in pharmacokinetics to use of an alternative modeling method to those modeling methods commonly used in pharmacokinetic studies. Previous examples presenting an advantageous use of the modeling method used in the current study can be found in full-text articles available completely free of cost on the authors' web pages at: http://www.uef.sav.sk/durisova.htm and http:// www.uef.sav.sk/advanced.htm.
Methods
The data published in the study [1] were employed. For modeling purposes, an advanced mathematical modeling method modeling method based on the concept of a dynamic system was used; see e.g. the studies cited above. The development of a mathematical model of each dynamic system H was based on the following simplifying assumptions: a) initial conditions of each dynamic system H be zero; b) pharmacokinetic processes occurring in the body once oral erythromycin administration; were linear and time-invariant, c) concentrations of erythromycin were the same throughout all subsystems of the dynamic systems H (where subsystems were integral parts of whole dynamic systems H); d) no barriers to the distribution and/or elimination of erythromycin existed. The modeling process used in the present study can be described as follows: was into the body, denoted
In the second step of the method, the dynamic systems were used to mathematically represent dynamic relations between erythromycin inputs into the body and erythromycin
In the third step of the method, the transfer function, denoted (see Eq. 1) was derived for each active system H by relating
C(s),
oral administration of erythromycin, denoted (the lower case letter e.g. the studies cited above and the following equation:
Thereafter, the dynamic system H of each volunteer was described with transfer function denoted see, e.g. the following studies [3-14] and references therein. Table 1 . Model-based estimates of primary pharmacokinetic variables were listed in Table 2 .
Volunteer No.1 was arbitrarily chosen from fourteen volunteers investigated in the previous study [1] and in the current study, to illustrate the results obtained. Figure 1 showed developed model of the dynamic system H. Analogous results also hold for all volunteers participating in the previous [1] and the current study.

Discussion
The dynamic systems used in the current study were mathematical objects, without any physiological application. They were used to model dynamic relationships between The current study again showed that mathematical and computational tools from system engineering can be successfully used in mathematical modeling in pharmacokinetics. Frequency response functions are complex functions, therefore modeling is performed in the complex domain. In addition, the modeling methods used to develop model frequency response functions are computationally intensive, and modeling require as a minimum partial knowledge of the theory of dynamic system, and an abstract way of thinking about the dynamic system under study.
The principle difference between pharmacokinetic modeling methods traditionally used in pharmacokinetic studies and modeling methods that use mathematical and computational tools from the theory of dynamic systems, is as follows: the former methods are based on modeling plasma (or blood) concentrationon modeling dynamic relationships between a mathematically represented drug inputs into the body and mathematically represent resulting plasma (or blood) concentration-time
e.g. the previous studies authored and/or coauthored by the author of the current study and the explanatory example, available free of cost at the author's Web page: http://www.uef.sav.sk/advanced.htm. As in previous studies, authored or co-authored by the author of the recent study, the development of mathematical models of the dynamic systems was based on the known inputs
